Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,738
datasets available to search
ShareScore release 0.9.0
Dataset results
2,738 results for “multiple sclerosis”
Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
ClinicalTrials.gov study NCT01212094. IPD Sharing: NO. Countries: 1. Publications: 2.
12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
ClinicalTrials.gov study NCT00735007. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT04602390. IPD Sharing: NO. Countries: 1. Publications: 0.
Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT01440101. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Idebenone for Primary Progressive Multiple Sclerosis
ClinicalTrials.gov study NCT01854359. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Epidural Stimulation in Multiple Sclerosis
ClinicalTrials.gov study NCT06019611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Home Based Functional Balance Intervention for Multiple Sclerosis
ClinicalTrials.gov study NCT07355387. IPD Sharing: NO. Countries: 1. Publications: 5.
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT00811395. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Isokinetic Exercises in Patients With Multiple Sclerosis
ClinicalTrials.gov study NCT03779724. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients
ClinicalTrials.gov study NCT01628393. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)
ClinicalTrials.gov study NCT03369665. IPD Sharing: YES. Countries: 18. Publications: 1.
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis
ClinicalTrials.gov study NCT00595920. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Expe
ClinicalTrials.gov study NCT02284568. IPD Sharing: Not stated. Countries: 10. Publications: 2.
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
ClinicalTrials.gov study NCT01864148. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod
ClinicalTrials.gov study NCT01499667. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Psychological Interventions for Multiple Sclerosis: Effects on Anxiety, Depression, and Cognition.
ClinicalTrials.gov study NCT07273604. IPD Sharing: YES. Countries: 1. Publications: 6.
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
ClinicalTrials.gov study NCT03085810. IPD Sharing: YES. Countries: 29. Publications: 5.
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
ClinicalTrials.gov study NCT03621761. IPD Sharing: NO. Countries: 1. Publications: 11.
COMparison Between All immunoTherapies for Multiple Sclerosis.
ClinicalTrials.gov study NCT03193866. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
ClinicalTrials.gov study NCT00489489. IPD Sharing: Not stated. Countries: 5. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.